- Home
- Publications
- Publication Search
- Publication Details
Title
The p53 Pathway in Glioblastoma
Authors
Keywords
-
Journal
Cancers
Volume 10, Issue 9, Pages 297
Publisher
MDPI AG
Online
2018-09-03
DOI
10.3390/cancers10090297
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Dual HDAC and PI3K Inhibition Abrogates NFκB- and FOXM1-Mediated DNA Damage Response to Radiosensitize Pediatric High-Grade Gliomas
- (2018) Sharmistha Pal et al. CANCER RESEARCH
- TP53 gain-of-function mutation promotes inflammation in glioblastoma
- (2018) Seok Won Ham et al. CELL DEATH AND DIFFERENTIATION
- Potent effect of the MDM2 inhibitor AMG232 on suppression of glioblastoma stem cells
- (2018) Nam-Gu Her et al. Cell Death & Disease
- Mutant p53 as a target for cancer treatment
- (2017) Michael J. Duffy et al. EUROPEAN JOURNAL OF CANCER
- Mutant p53 in Cancer: Accumulation, Gain-of-Function, and Therapy
- (2017) Xuetian Yue et al. JOURNAL OF MOLECULAR BIOLOGY
- Combination therapy in a xenograft model of glioblastoma: enhancement of the antitumor activity of temozolomide by an MDM2 antagonist
- (2017) Haiyan Wang et al. JOURNAL OF NEUROSURGERY
- The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary
- (2016) David N. Louis et al. ACTA NEUROPATHOLOGICA
- The p53 Pathway: Origins, Inactivation in Cancer, and Emerging Therapeutic Approaches
- (2016) Andreas C. Joerger et al. Annual Review of Biochemistry
- The lncRNA H19 interacts with miR-140 to modulate glioma growth by targeting iASPP
- (2016) Haiting Zhao et al. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
- A Designed Inhibitor of p53 Aggregation Rescues p53 Tumor Suppression in Ovarian Carcinomas
- (2016) Alice Soragni et al. CANCER CELL
- Reactivation of mutant p53 by a dietary-related compound phenethyl isothiocyanate inhibits tumor growth
- (2016) M Aggarwal et al. CELL DEATH AND DIFFERENTIATION
- Enhanced efficacy of combined HDAC and PARP targeting in glioblastoma
- (2016) Rikke D. Rasmussen et al. Molecular Oncology
- Long non-coding RNAs as novel therapeutic targets in cancer
- (2016) Giovanni Lavorgna et al. PHARMACOLOGICAL RESEARCH
- Mutant p53 promotes tumor progression and metastasis by the endoplasmic reticulum UDPase ENTPD5
- (2016) Fotini Vogiatzi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Inhibition of histone deacetylases sensitizes glioblastoma cells to lomustine
- (2016) Mikkel Staberg et al. CELLULAR ONCOLOGY
- Cancer therapeutic approach based on conformational stabilization of mutant p53 protein by small peptides
- (2016) Perry Tal et al. Oncotarget
- A novel histone deacetylase inhibitor, CKD5, has potent anti-cancer effects in glioblastoma
- (2016) Seung Ah Choi et al. Oncotarget
- SAHA and/or MG132 reverse the aggressive phenotypes of glioma cells: An in vitro and vivo study
- (2016) Xue-feng Yang et al. Oncotarget
- Sensitivity to PRIMA-1MET is associated with decreased MGMT in human glioblastoma cells and glioblastoma stem cells irrespective of p53 status
- (2016) Mariia Patyka et al. Oncotarget
- miRNA Multiplayers in glioma. From bench to bedside
- (2015) Katarzyna Rolle ACTA BIOCHIMICA POLONICA
- Molecular and Genomic Alterations in Glioblastoma Multiforme
- (2015) Ines Crespo et al. AMERICAN JOURNAL OF PATHOLOGY
- Preclinical Efficacy of the MDM2 Inhibitor RG7112 in MDM2-Amplified and TP53 Wild-type Glioblastomas
- (2015) M. Verreault et al. CLINICAL CANCER RESEARCH
- Nonsurgical treatment of recurrent glioblastoma
- (2015) O. Gallego Current Oncology
- Actin cytoskeleton organization, cell surface modification and invasion rate of 5 glioblastoma cell lines differing in PTEN and p53 status
- (2015) Cholpon S. Djuzenova et al. EXPERIMENTAL CELL RESEARCH
- Mutant p53 cooperates with the SWI/SNF chromatin remodeling complex to regulateVEGFR2in breast cancer cells
- (2015) Neil T. Pfister et al. GENES & DEVELOPMENT
- The MDM2 Inhibitor AMG 232 Demonstrates Robust Antitumor Efficacy and Potentiates the Activity of p53-Inducing Cytotoxic Agents
- (2015) J. Canon et al. MOLECULAR CANCER THERAPEUTICS
- Gain-of-function p53 mutants co-opt chromatin pathways to drive cancer growth
- (2015) Jiajun Zhu et al. NATURE
- Discovery and annotation of long noncoding RNAs
- (2015) John S Mattick et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Preclinical activity of combined HDAC and KDM1A inhibition in glioblastoma
- (2015) Melissa M. Singh et al. NEURO-ONCOLOGY
- Histone Deacetylase Inhibitors Resensitize EGFR/EGFRvIII-Overexpressing, Erlotinib-Resistant Glioblastoma Cells to Tyrosine Kinase Inhibition
- (2015) Katrin Liffers et al. Targeted Oncology
- Discovery and annotation of long noncoding RNAs
- (2015) John S Mattick et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Stress Response of Glioblastoma Cells Mediated by miR-17-5p Targeting PTEN and the Passenger Strand miR-17-3p Targeting MDM2
- (2015) Haoran Li et al. Oncotarget
- A Novel PTEN/Mutant p53/c-Myc/Bcl-XL Axis Mediates Context-Dependent Oncogenic Effects of PTEN with Implications for Cancer Prognosis and Therapy
- (2015) Xiaoping Huang et al. NEOPLASIA
- Mutant p53 in Cancer: New Functions and Therapeutic Opportunities
- (2014) Patricia A.J. Muller et al. CANCER CELL
- Targetable Signaling Pathway Mutations Are Associated with Malignant Phenotype in IDH-Mutant Gliomas
- (2014) H. Wakimoto et al. CLINICAL CANCER RESEARCH
- Mutant TP53 Posttranslational Modifications: Challenges and Opportunities
- (2014) Thuy-Ai Nguyen et al. HUMAN MUTATION
- Regulatory Roles of miRNA in the Human Neural Stem Cell Transformation to Glioma Stem Cells
- (2014) Shuang Liu et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Two mature products of MIR-491 coordinate to suppress key cancer hallmarks in glioblastoma
- (2014) X Li et al. ONCOGENE
- Apoptosis Therapy in Cancer: The First Single-molecule Co-activating p53 and the Translocator Protein in Glioblastoma
- (2014) Simona Daniele et al. Scientific Reports
- MiR-125b acts as an oncogene in glioblastoma cells and inhibits cell apoptosis through p53 and p38MAPK-independent pathways
- (2013) N Wu et al. BRITISH JOURNAL OF CANCER
- The Somatic Genomic Landscape of Glioblastoma
- (2013) Cameron W. Brennan et al. CELL
- Tumor suppression: Putting p53 in context
- (2013) Kevin D Mills CELL CYCLE
- Downregulation of miR-124 promotes the growth and invasiveness of glioblastoma cells involving upregulation of PPP1R13L
- (2013) WEI-HUA ZHAO et al. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal
- (2013) J. Gao et al. Science Signaling
- Current understanding of the role and targeting of tumor suppressor p53 in glioblastoma multiforme
- (2013) Bryant England et al. TUMOR BIOLOGY
- Discovery of RG7112: A Small-Molecule MDM2 Inhibitor in Clinical Development
- (2013) Binh Vu et al. ACS Medicinal Chemistry Letters
- Spliced MDM2 isoforms promote mutant p53 accumulation and gain-of-function in tumorigenesis
- (2013) Tongsen Zheng et al. Nature Communications
- Tumour-associated mutant p53 drives the Warburg effect
- (2013) Cen Zhang et al. Nature Communications
- Allele-Specific p53 Mutant Reactivation
- (2012) Xin Yu et al. CANCER CELL
- Mutant p53 Disrupts Mammary Tissue Architecture via the Mevalonate Pathway
- (2012) William A. Freed-Pastor et al. CELL
- Mutant p53 is a transcriptional co-factor that binds to G-rich regulatory regions of active genes and generates transcriptional plasticity
- (2012) Timo Quante et al. CELL CYCLE
- Inhibition of Histone Deacetylation Potentiates the Evolution of Acquired Temozolomide Resistance Linked to MGMT Upregulation in Glioblastoma Xenografts
- (2012) G. J. Kitange et al. CLINICAL CANCER RESEARCH
- PARP-1 protein expression in glioblastoma multiforme
- (2012) A. Galia et al. EUROPEAN JOURNAL OF HISTOCHEMISTRY
- P14ARF inhibits human glioblastoma–induced angiogenesis by upregulating the expression of TIMP3
- (2012) Abdessamad Zerrouqi et al. JOURNAL OF CLINICAL INVESTIGATION
- Targeting Mutant p53 in Human Tumors
- (2012) Brian D. Lehmann et al. JOURNAL OF CLINICAL ONCOLOGY
- Targeting p53 in Vivo: A First-in-Human Study With p53-Targeting Compound APR-246 in Refractory Hematologic Malignancies and Prostate Cancer
- (2012) Sören Lehmann et al. JOURNAL OF CLINICAL ONCOLOGY
- R280T mutation of p53 gene promotes proliferation of human glioma cells through GSK-3β/PTEN pathway
- (2012) Chenli Lin et al. NEUROSCIENCE LETTERS
- The TP53 website: an integrative resource centre for the TP53 mutation database and TP53 mutant analysis
- (2012) Bernard Leroy et al. NUCLEIC ACIDS RESEARCH
- Histone deacetylase inhibitors suppress mutant p53 transcription via histone deacetylase 8
- (2012) W Yan et al. ONCOGENE
- The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data: Figure 1.
- (2012) Ethan Cerami et al. Cancer Discovery
- Integrins and p53 pathways in glioblastoma resistance to temozolomide
- (2012) Sophie Martin et al. Frontiers in Oncology
- Multiple Stress Signals Activate Mutant p53 In Vivo
- (2011) Y.-A. Suh et al. CANCER RESEARCH
- Mutant p53 protein, master regulator of human malignancies: a report on the fifth Mutant p53 Workshop
- (2011) G Blandino et al. CELL DEATH AND DIFFERENTIATION
- SAHA shows preferential cytotoxicity in mutant p53 cancer cells by destabilizing mutant p53 through inhibition of the HDAC6-Hsp90 chaperone axis
- (2011) D Li et al. CELL DEATH AND DIFFERENTIATION
- p53 and its mutants in tumor cell migration and invasion
- (2011) Patricia A. J. Muller et al. JOURNAL OF CELL BIOLOGY
- Functional Inactivation of Endogenous MDM2 and CHIP by HSP90 Causes Aberrant Stabilization of Mutant p53 in Human Cancer Cells
- (2011) D. Li et al. MOLECULAR CANCER RESEARCH
- Modulation of the Vitamin D3 Response by Cancer-Associated Mutant p53
- (2010) Perry Stambolsky et al. CANCER CELL
- Integrated Genomic Analysis Identifies Clinically Relevant Subtypes of Glioblastoma Characterized by Abnormalities in PDGFRA, IDH1, EGFR, and NF1
- (2010) Roel G.W. Verhaak et al. CANCER CELL
- Isocitrate dehydrogenase-1 mutations: a fundamentally new understanding of diffuse glioma?
- (2010) Nanne K Kloosterhof et al. LANCET ONCOLOGY
- Frequency variations in the methylated pattern of p73/p21 genes and chromosomal aberrations correlating with different grades of glioma among south Indian population
- (2010) Mahalakshmi Palani et al. MEDICAL ONCOLOGY
- Single-Molecule characterization of oligomerization kinetics and equilibria of the tumor suppressor p53
- (2010) S. Rajagopalan et al. NUCLEIC ACIDS RESEARCH
- Pharmacological reactivation of mutant p53: from protein structure to the cancer patient
- (2010) K G Wiman ONCOGENE
- The stem cell niche in health and malignancy
- (2010) Monika L. Burness et al. SEMINARS IN CANCER BIOLOGY
- Drug discovery and mutant p53
- (2010) Magda M. Maslon et al. TRENDS IN CELL BIOLOGY
- PRIMA-1 Reactivates Mutant p53 by Covalent Binding to the Core Domain
- (2009) Jeremy M.R. Lambert et al. CANCER CELL
- MicroRNA-34a Inhibits Glioblastoma Growth by Targeting Multiple Oncogenes
- (2009) Y. Li et al. CANCER RESEARCH
- FAM/USP9x, a Deubiquitinating Enzyme Essential for TGFβ Signaling, Controls Smad4 Monoubiquitination
- (2009) Sirio Dupont et al. CELL
- Mutant p53 Drives Invasion by Promoting Integrin Recycling
- (2009) Patricia A.J. Muller et al. CELL
- Non-apoptotic Fas signaling regulates invasiveness of glioma cells and modulates MMP-2 activity via NFκB-TIMP-2 pathway
- (2009) Pawel Wisniewski et al. CELLULAR SIGNALLING
- A survey of glioblastoma genomic amplifications and deletions
- (2009) Shailaja K. Rao et al. JOURNAL OF NEURO-ONCOLOGY
- Cytoplasmic functions of the tumour suppressor p53
- (2009) Douglas R. Green et al. NATURE
- Modulation of gene expression in U251 glioblastoma cells by binding of mutant p53 R273H to intronic and intergenic sequences
- (2009) Marie Brázdová et al. NUCLEIC ACIDS RESEARCH
- Structural Biology of the Tumor Suppressor p53
- (2008) Andreas C. Joerger et al. Annual Review of Biochemistry
- Glioblastoma with Adipocyte-Like Tumor Cell Differentiation-Histological and Molecular Features of a Rare Differentiation Pattern
- (2008) Christian H. Rickert et al. BRAIN PATHOLOGY
- Yes and PI3K Bind CD95 to Signal Invasion of Glioblastoma
- (2008) Susanne Kleber et al. CANCER CELL
- PTEN Has Tumor-Promoting Properties in the Setting of Gain-of-Function p53 Mutations
- (2008) Y. Li et al. CANCER RESEARCH
- A novel p53 rescue compound induces p53-dependent growth arrest and sensitises glioma cells to Apo2L/TRAIL-induced apoptosis
- (2008) L Weinmann et al. CELL DEATH AND DIFFERENTIATION
- p53 and Pten control neural and glioma stem/progenitor cell renewal and differentiation
- (2008) Hongwu Zheng et al. NATURE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started